The company plans to address the FDA's concerns and resubmit its application for the product, which aims to treat so-called "off episodes", which affects nearly all patients of Parkinson's, heightening symptoms such as tremors and difficulty in walking, as medication wears off.
US FDA declines to approve Supernus' Park... - Cure Parkinson's
US FDA declines to approve Supernus' Parkinson's combination again
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Thanks for sharing! Sounds promising!
FDA Issues Complete Response Letter for Apomorphine Infusion Device SPN-830 in Parkinson Disease Treatment
Not what you're looking for?
You may also like...
New to Parkinson's
Was just diagnosed with early stages of PD.
Dr prescribed Rasagiline 1mg to start off with, but...
Autopsies tell us the secrets of Parkinson's...
The brains of Parkinson's patients tell us some of the secrets of the disease at autopsy...
"For...
US FDA "Emergency" Fast Tracks COVID-19 Diagnostic Testing
As of February 29, 2020, In response to multiple complaints about the failure of current US test...
Adding Lexapro to Sinemet for my Parkinson's
Hi folks, I'm willason, I'm new here as of 10/9/18, and this is my first post. I'm a male in my...
Eating to reverse Parkinson's - Update
Hi all
This is a link to my latest vlog, which is an update of my progress with taking Mannitol and...
Related Posts
Eating to reverse Parkinson's - Update #2
ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE
Reducing oxidative stress and inflammation to slow Parkinson's disease - Waking up dormant dopaminergic neurons to reverse Parkinson's disease
National Bill to End Parkinson's
